Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2021 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2021.107961
Abstract: Background COVID-19, which is a disease caused by the SARS-CoV-2 virus, has spread around the world since late 2019. Studies have found associations between the rising levels of TNF-α and severe COVID-19 cases. Hence, TNF-α… read more here.
Keywords: randomized controlled; covid cases; adalimumab; controlled trial ... See more keywords
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone
Sign Up to like & getrecommendations! Published in 2023 at "Infectious Diseases"
DOI: 10.1080/23744235.2023.2187081
Abstract: Abstract Background The combined effectiveness of remdesivir and dexamethasone in subgroups of hospitalised patients with COVID-19 is poorly investigated. Methods In this nationwide retrospective cohort study, we included 3826 patients with COVID-19 hospitalised between February… read more here.
Keywords: hospitalised patients; remdesivir dexamethasone; treatment; patients covid ... See more keywords
Real World Impact of Remdesivir and Dexamethasone on Clinical Outcomes of Severe Coronavirus Disease 2019 in a Community Hospital.
Sign Up to like & getrecommendations! Published in 2022 at "Military medicine"
DOI: 10.1093/milmed/usac052
Abstract: BACKGROUND Evidence has emerged showing potential benefit of Remdesivir and dexamethasone in severe coronavirus disease 2019 (COVID-19) but results from large randomized control trials are conflicting. While initial data for dexamethasone indicated a mortality benefit,… read more here.
Keywords: community hospital; impact; remdesivir dexamethasone; dexamethasone ... See more keywords
Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030474
Abstract: Although some studies have reported prognostic factors for coronavirus disease 2019 (COVID-19), they were conducted before standard treatment with remdesivir and dexamethasone was implemented. This retrospective, observational study was conducted to evaluate various prognostic factors… read more here.
Keywords: covid pneumonia; remdesivir dexamethasone; day mortality; treatment ... See more keywords